Industry collaboration aims to advance the development of synthetic arms in clinical trials
7 January 2021
Phesi, a data-driven provider of AI-powered clinical development analytics products and solutions, has announced it has entered into an exclusive strategic collaboration with clinical AI technology company, Sensyne Health, which is making an equity investment of $10 million in Phesi.
